Live from the NIH registry
Studies recruiting near Amarillo right now
Top 25 of 98 recruiting studies, sorted by proximity — each links to its official registry page
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Texas Oncology - West Texas — Amarillo, Texas (1.6 mi)
· Sponsor: SCRI Development Innovations, LLC
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Malignancy
N/A
Observational 240 participants sought
The Don and Sybil Harrington Cancer Center — Amarillo, Texas (1.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
PharmaTex Research, LLC — Amarillo, Texas (1.6 mi)
· Sponsor: Novo Nordisk A/S
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Heart Failure
Phase 2
Interventional 200 participants sought
Amarillo Medical Specialists — Amarillo, Texas (1.6 mi)
· Sponsor: Novo Nordisk A/S
Pelacarsen Roll-over Extension Program
Atherosclerotic Cardiovascular Disease
Phase 3
Interventional 599 participants sought
Pharma Tex Research — Amarillo, Texas (1.6 mi)
· Sponsor: Novartis Pharmaceuticals
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Harrington Cancer Center ( Site 0061) — Amarillo, Texas (1.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,000 participants sought
Research Site — Amarillo, Texas (1.6 mi)
· Sponsor: AstraZeneca
Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
Hypertriglyceridemia
Phase 2
Interventional 316 participants sought
Marea Site 322 — Amarillo, Texas (1.6 mi)
· Sponsor: Marea Therapeutics
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction
Phase 3
Interventional 5,056 participants sought
PharmaTex Research, LLC — Amarillo, Texas (1.6 mi)
· Sponsor: Amgen
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
The Don and Sybil Harrington Cancer Center — Amarillo, Texas (1.6 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Amarillo, TX Investigative Site 10045 — Amarillo, Texas (1.6 mi)
· Sponsor: Colorado Prevention Center
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Lupus Erythematosus, Systemic
Phase 3
Interventional 600 participants sought
Amarillo Center for Clinical Research — Amarillo, Texas (1.6 mi)
· Sponsor: Janssen Research & Development, LLC
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma
Phase 3
Interventional 62 participants sought
Texas Tech University Health Sciences Center-Amarillo — Amarillo, Texas (1.6 mi)
· Sponsor: Children's Oncology Group
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 2, Phase 3
Interventional 378 participants sought
The Don and Sybil Harrington Cancer Center — Amarillo, Texas (1.6 mi)
· Sponsor: SWOG Cancer Research Network
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Amarillo, Texas (1.6 mi)
· Sponsor: 89bio, Inc.
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
Obesity, Overweight
Phase 3
Interventional 2,340 participants sought
Kailera Clinical Site — Amarillo, Texas (1.6 mi)
· Sponsor: Kailera
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Obesity, Overweight
Phase 2
Interventional 360 participants sought
Amarillo Medical Specialists /ID# 282380 — Amarillo, Texas (1.6 mi)
· Sponsor: AbbVie
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
Harrington Cancer Center — Amarillo, Texas (1.6 mi)
· Sponsor: Agendia
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Amarillo, Texas (1.6 mi)
· Sponsor: Akero Therapeutics, Inc
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Neovascular Age-Related Macular Degeneration (nAMD)
Phase 3
Interventional 480 participants sought
Southwest Retina Specialist - Panhandle Eye group, LLP — Amarillo, Texas (1.6 mi)
· Sponsor: 4D Molecular Therapeutics
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Atrial Fibrillation (AF)
Phase 3
Interventional 15,364 participants sought
PharmaTex Research — Amarillo, Texas (1.6 mi)
· Sponsor: Regeneron Pharmaceuticals
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
Acute Gout Flare, Gout Attack
Phase 2, Phase 3
Interventional 300 participants sought
Amarillo Center of Clinical Research — Amarillo, Texas (1.6 mi)
· Sponsor: Olatec Therapeutics, Inc.
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10045 Amarillo, TX Investigational Site — Amarillo, Texas (1.6 mi)
· Sponsor: Colorado Prevention Center
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Phase 2, Phase 3
Interventional 690 participants sought
Texas Oncology - Amarillo Cancer Center — Amarillo, Texas (1.6 mi)
· Sponsor: Bristol-Myers Squibb
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
The Don and Sybil Harrington Cancer Center — Amarillo, Texas (1.6 mi)
· Sponsor: NRG Oncology